<<

Pediatric - Pigmented Lesions

OPTI-West/Western University of Health Sciences- Silver Falls Dermatology Presenters: Bryce Lynn Desmond, DO; Ben Perry, DO Contributions from: Lauren Boudreaux, DO; Stephanie Howerter, DO; Collin Blattner, DO; Karsten Johnson, DO Disclosures

• We have no financial or conflicts of interest to report Basic Science

origin • Migrate to , , leptomeninges, retina, choroid, iris, mucous membrane epithelium, inner ear, cochlea, vestibular system • Embryology • First appearance at the end of the 1st trimester • Able to synthesize at the beginning of the 2nd trimester • Ratio of to basal cells is 1:10 in and 1:4 in hair • Equal numbers of melanocytes across different races • Type, number, size, dispersion, and degree of melanization of the melanosomes determines pigmentation of Ota

• A.k.a. Nevus Fuscocoeruleus Ophthalmomaxillaris • Onset at birth (50-60%) or 2nd decade • Larger than , does not typically regress spontaneously • Often first 2 branches of trigeminal nerve • Other involved sites include ipsilateral sclera (~66%), tympanum (55%), nasal mucosa (30%). • ~50 cases of reported • Reported rates of malignant transformation, 0.5%-25% in Asian populations • Ocular melanoma of choroid, orbit, chiasma, meninges have been observed in patients with clinical ocular . • Acquired variation seen in primarily Chinese or Japanese adults is called Hori’s nevus • Tx: Q-switched ruby, alexandrite, and Nd:Yag lasers Congenital dermal melanocytosis

• AKA: Mongolian Spot • Usually apparent at birth or within the first few weeks of life • Regresses in >95% by age 18 years; more likely to persist in extensive or extra-sacral variants; most common in Asians and blacks • Presents as a single or multiple, blue-gray patch(es) with indefinite borders; favors the lumbosacral area and buttocks > back • Varies in size from a 2-20+ cm • CALM and melanocytic nevi within Mongolian spots often have a ‘halo’ that lacks dermal melanocytes • DDx: ecchymosis, child abuse, patch , venous malformation • Extensive lesions with pigmentovascularis (type 2, 4 , or 5) Nevus Fuscocaeruleus Acromiodeltoideus • AKA: • Bimodal age of onset: • 50–60% present at birth or before 1 year of age • 40–50% appear at or around puberty • All persist lifelong • More common in Asians and ; females > males • Involves areas of skin innervated by the posterior supraclavicular and lateral brachiocutaneous nerves • Typically unilateral Café-au-Lait Macule (CALM)

• Light to dark brown macule or patch • 10-20% of normal population can have a single lesion • Generally 2-5 cm in diameter • Conditions associated: • • McCune-Albright syndrome (coast of Maine) • • LEOPARD syndrome • Fanconi anemia • • Ataxia • MEN 1 and 2B • • More…… Ephelides

• Light brown macules in sun- exposed areas • Onset typically within first 3 years of age • If acquired after this, can be a marker for UV-induced damage • Histo: NORMAL # of melanocytes, INCREASED pigment in keratinocytes Simplex and Oral Melanotic Macules

• Common in younger patients • Increased numbers in childhood or puberty • Sometimes eruptive → • Not related to sun exposure • Oral melanotic macules • Primarily in adults over 40 • Multiple lentigines seen in association with several genetic disorders: • LEOPARD syndrome • • Tay syndrome • Pipkin syndrome • Cronkite-Canada syndrome • Bannayan-Riley Ruvalcaba syndrome • Cowden’s disease • Peutz-Jeghers syndrome • Laugier-Hunziker syndrome • More…. LEOPARD syndrome Gene: PTPN11 , AD • Lentigines • ECG abnormalities • Ocular • Pulmonary • Abnormal genitalia • Retardation of growth • Deafness • *** LEOPARD Syndrome has no mucosal involvement LEOPARD syndrome Noonan Syndrome AD, PTPN11 • Wide set ears • Ulerythema ophryogenes ( pilaris rubra atrophicans faciei) • • Undescended testes • Low posterior neck hairline • Pulmonary stenosis • formation • CALMs CARNEY Complex

NAME LAMB • Nevi • Lentigines • Atrial myxoma • Most common on lips, face, sclera and vulva. • Myxomas (myxoid tumors) • Atrial myxomas • Tumors of heart tissue, often originate in atria • Ephelides & Endocrine • May obstruct blood flow through the heart → • Sertoli tumors fainting, shortness of breath, chest pain • Psammomatous melanotic • Mucocutaneous myxomas schwannomas • or nodules • Pigmented pituitary adenomas • Various anatomic sites: breasts, shoulders, oral • Cushingoid features mucosa and tongue. • Blue nevi – can be found anywhere on body CARNEY complex

AD inheritance • PRKAR1A gene • Encodes the type 1A regulatory subunit of protein A • Cell cycle regulation, growth, and/or proliferation. • Referral to and Peutz-Jeghers

AD, STK11/LKB1 gene (Encodes serine-threonine kinase tumor suppressor)

• Mucocutaneous melanotic macules • Onset before age 5, often fades after puberty • Mouth • Lips • Buccal mucosa • Gingiva • Tongue • Eyes • Palmoplantar • Anogenital Peutz-Jeghers

• Hamartomatous polyps • Bleeding • Intussusception (50%) • Increased incidence of malignancy • 47% mortality rate from cancer by 57 yrs of age • GI adenocarcinoma • Colorectal- 39%, Stomach- 29% • Colonoscopy, upper endoscopy q2-3 yrs beginning in late teens • Breast cancer • Female incidence 45-50% • Mammogram and breast MRI yearly starting at age 25 • Pancreatic cancer • MRCP q1-2 years starting at age 25 to 30 • Ovarian, uterine, cervical, testicular cancer Laugier-Hunziker Syndrome

Sporadic inheritence • Mucocutaneous melanotic macules • Oral: Buccal, lip, tongue, gingiva • Melanonychia • Longitudinal • Half • Complete • Genital • Neck • Trunk • Palmplantar • Cutaneous pigmentation may fade over time, oral pigmentation often permanent • No increased risk of cancer • Dx of exclusion • R/o Peutz-Jeghers, Addison’s disease, SLE Bannayan-Riley Ruvalcaba AD, PTEN mutation • Allelic to Cowden’s syndrome • Genital Lentigines (penile > vulvar) • • Intestinal polyposis • • Hemangiomas • • Mental retardation

• 2 mm to >2 cm well-circumscribed, dome- shaped, red or pigmented or nodule • Comprises ~1% of excised melanocytic lesions • Typically children or young adults (<40 yrs) • Majority are acquired, up to 7% congenital • M/c on the head or neck • Histologically can mimic melanoma • Differentiate with S100A6, Ki-67, P16 Spitz Nevus

• Pathogenesis • No particular etiologic factors have been identified to correspond with Spitz nevi • Widespread eruptive Spitz nevi have been associated with many of the same triggers as for common nevi: • HIV infection • Addison’s disease • Chemotherapy • • Puberty • Trauma • Spitz nevi with pregnancy and puberty • Possible hormonally-activated dormant nevi • Atypical spitz nevus risk factors for metastasis: Ulceration, ↑ Breslow depth, atypical mitoses, H-RAS mutation • Treatment: Full-thickness excision (Speckled lentiginous nevus)

• Tan patch containing brown macules that develop over time • Can contain atypical nevi and small and medium-sized congenital nevi • Typically larger nevus spilus • No gender predilection • Small risk of cutaneous melanoma Clinical Features and Associations

• More common on the trunk and extremities • Tan patch persists, central nevi increase over time • Cutaneous melanoma arising within a nevus spilus has been reported • Associated syndromes involving nevus spilus include • Phakomatosis pigmentovascularis types III and IV • Phakomatosis pigmentokeratotica • “Speckled lentiginous nevus syndrome” • Ipsilateral dysesthesia, muscular weakness or hyperhidrosis in patients with nevus spilus (Sutton’s)

• Nevus with peripheral white halo • Epidemiology • Most common in teenagers with multiple nevi • Mean age is 15 years • Typically appears on the back • No Gender predilection • Pathogenesis • Development thought to involve either: 1. An immune response against cells with tumor progression • This theory is not supported by histologic evaluations 2. An autoimmune (cell-mediated and/or humoral) reaction against non-specifically altered nevomelanocytes, such as in . • The now favored hypothesis Halo Nevus (Sutton’s)

• May have underlying vitiligo (~20%) • Can occur in the setting of melanoma (local or elsewhere) • More common in adults • Can develop in association with • Histopathology • Residual melanocytes with heavy infiltration of lymphocytes and histiocytes • Management • Full skin examination to r/o melanoma and vitiligo Melanoma

• Malignant tumor that arises from melanocytes • Leading cause of death • Incidence rates of melanoma have increased over the past four decades by three- to five-fold • Mortality rates began to stabilize in the early 1990s • Rare in pediatric population • However, 3% of all pediatric cancers are melanoma • The annual transformation rate of a single mole into melanoma is estimated at ≤0.0005% for individuals younger than 40 years. • Misdiagnosed in pediatric population 40% of the time • Prepubescent patients tend to have thicker lesions, can be difficult to distinguish from atypical Spitz nevi histologically • Favorable prognosis compared to adults • Age is a more important prognostic factor for pediatric patients than sentinel lymph node positivity

Becker’s Nevus

• Acquired, unilateral hyperpigmentation +/- underlying smooth muscle • Usually involving the upper trunk of adolescent males • Occasionally may present earlier in life on extremities • Etiology is unknown, but the lesion is associated with a localized increase in androgen receptors • No malignant transformation • Becker’s Nevus Syndrome • Becker’s nevus with unilateral breast and areolar hypoplasia, focal , , limb asymmetry, and spina bifida, scoliosis • Evaluate for musculoskeletal dysfunction with referral as needed • Histopathology • Epidermal thickening, elongation of the rete ridges, and hyperpigmentation of the basal layer with increased melanocytes Blue Nevus

• Blue to blue–black firm papule, nodule or plaques, often with an onset during childhood or adolescence • Aggregates of dermal, dendritic, heavily pigmented melanocytes • Approximately 50% are found on the dorsal aspect of the hands and feet, with the face and scalp being other common sites • Somatic activating in GNA11 and GNAQ (primarily the latter) have been detected in 65–75% of blue nevi References

• Cancer Facts and Figures 2017. American Cancer Society. http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-048738.pdf. Accessed January 10, 2017. • Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. 2005; 115(3):649-57. • Niiyama S, Katsuoka K. Laugier-Hunziker syndrome. Eur J Dermatol. 2013 Apr 1;23(2):284-5. • Kosari P, Kelly KM. Asymptomatic lower lip hyperpigmentation from Laugier-Hunziker syndrome. Cutis. 2011 Nov;88(5):235-6. • Lampe AK, Hampton PJ, Woodford-Richens K, Tomlinson I, Lawrence CM, Douglas FS. Laugier-Hunziker syndrome: an important for Peutz-Jeghers syndrome. Journal of . 2003 Jun 1;40(6):e77. • Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz–Jeghers syndrome. Oncogene. 2007 Dec 13;26(57):7825-32. • Scully CC, Hegarty A. The oral cavity and lips. Rook's Textbook of Dermatology, Eighth Edition. 2004:1-29. • Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, Roberts AE, Robinson W, Takemoto CM, Noonan JA. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2010 Oct 1;126(4):746-59. • Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. Journal of Clinical . 2005 Jul 20;23(21):4735- 41. References

• Roaten JB, Partrick DA, Bensard D, Pearlman N, Gonzalez R, Fitzpatrick J, McCarter MD. Survival in sentinel lymph node–positive pediatric melanoma. Journal of pediatric surgery. 2005 Jun 30;40(6):988-92. • van Dijk MC, Bernsen MR, Ruiter DJ. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. The American journal of surgical . 2005 Sep 1;29(9):1145-51. • Luo S, Sepehr A, Tsao H. Spitz nevi and other Spitzoid lesions: Part I. Background and diagnoses. Journal of the American Academy of Dermatology. 2011 Dec 31;65(6):1073-84. • Aouthmany M, Weinstein M, Zirwas MJ, Brodell RT. The natural history of halo nevi: a retrospective case series. Journal of the American Academy of Dermatology. 2012 Oct 31;67(4):582-6. • Ezzedine K, Diallo A, Léauté-Labrèze C, Seneschal J, Mossalayi D, AlGhamdi K, Prey S, Bouchtnei S, Cario-André M, Boralevi F, Jouary T. Halo nevi association in nonsegmental vitiligo affects age at onset and pattern. Archives of dermatology. 2012 Apr 1;148(4):497-502. • Martínez-Quintana E, Rodríguez-González F. LEOPARD syndrome: clinical features and gene mutations. Molecular syndromology. 2012 Aug 29;3(4):145-57. • Salpea P, Stratakis CA. Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics. Molecular and cellular endocrinology. 2014 Apr 5;386(1):85-91. • Crowson AN, Magro CM, Mihm Jr MC. The melanocytic proliferations: a comprehensive textbook of pigmented lesions. John Wiley & Sons; 2014 Jan 6. • Ly L, Christie M, Swain S, Winship I, Kelly JW. Melanoma (s) arising in large segmental speckled lentiginous nevi: A case series. Journal of the American Academy of Dermatology. 2011 Jun 1;64(6):1190-3. References

• Happle R. Speckled lentiginous nevi: no longer one single disorder. Archives of dermatology. 2010 Feb 1;146(2):204-. • Bhat RM, Pinto HP, Dandekeri S, Ambil SM. Acquired bilateral -like macules with Mucosal involvement: A new variant of Hori's nevus. Indian journal of dermatology. 2014 May;59(3):293. • Polder KD, Landau JM, VERGILIS‐KALNER IJ, Goldberg LH, Friedman PM, Bruce S. Laser eradication of pigmented lesions: a review. Dermatologic Surgery. 2011 May 1;37(5):572-95. • Gerami P, Pouryazdanparast P, Vemula S, Bastian BC. Molecular analysis of a case of nevus of ota showing progressive evolution to melanoma with intermediate stages resembling cellular blue nevus. The American Journal of Dermatopathology. 2010 May 1;32(3):301-5. • Chen TS, Goldyne ME, Mathes EF, Frieden IJ, Gilliam AE. Pediatric teledermatology: observations based on 429 consults. Journal of the American Academy of Dermatology. 2010 Jan 31;62(1):61-6. • Thomas AC, Zeng Z, Rivière JB, O’shaughnessy R, Al-Olabi L, Onge JS, Atherton DJ, Aubert H, Bagazgoitia L, Barbarot S, Bourrat E. Mosaic activating mutations in GNA11 and GNAQ are associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis. Journal of Investigative Dermatology. 2016 Apr 30;136(4):770-8. • Wise SR, Capra G, Martin P, Wallace D, Miller C. Malignant melanoma transformation within a nevus of Ito. Journal of the American Academy of Dermatology. 2010 May 31;62(5):869-74. Thank you to the AOCD for this opportunity!

Thank you to our residency program for their support and contributions!